EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acetyl-CoA synthetase mutations affect the susceptibility of Plasmodium falciparum to antimalarial drugs

Wei Zhao iD, Zheng Xiang, Weilin Zeng, Yucheng Qin, Maohua Pan, Yanrui Wu, Mengxi Duan, Ye Mou, Tao Liang, Yanmei Zhang, Cheng Liu, Xiuya Tang und 4 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01026-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Wei Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Provincial Key Laboratory of Public Health and Biosafety & Department of Pathogen Biology and Immunology, Faculty of Basic Medical Science, Ku…. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, Coenzyme A Ligases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Natural Science Foundation of China, Yunnan University Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmodium falciparum acetyl-CoA synthetase (PfAcAS) is an important source of acetyl-CoA. We detected mutations S868G and V950I in PfAcAS by whole-genome sequencing analysis in certain recrudescent parasites after treatment with artesunate and dihydroartemisinin-piperaquine. Using CRISPR/Cas9 technology, we engineered parasite lines to carry the PfAcAS S868G and V950I mutations in two genetic backgrounds and evaluated their susceptibilities to antimalarial drugs in vitro . The results demonstrated that PfAcAS S868G and V950I mutations alone or in combination affected the susceptibility of P. falciparum to several antimalarial drugs, including the artemisinin derivatives (dihydroartemisinin, artesunate, and artemether) and chloroquine, although absolute changes in susceptibilities were modest. IMPORTANCE Malaria, an infectious disease caused by Plasmodium parasites and transmitted by mosquitoes, continues to be one of the most pressing public health challenges worldwide. P. falciparum has demonstrated reduced sensitivity to artemisinin-based combination therapies (ACTs), thereby intensifying the difficulties associated with malaria management. Currently, only a limited number of molecular markers exist for identifying drug resistance in P. falciparum , and these markers do not fully elucidate the mechanisms behind this resistance. In this study, we performed whole-genome sequencing analysis on P. falciparum strains that reemerged following ACT treatment. We aim to identify molecules potentially associated with drug resistance, which may provide new molecular markers for monitoring drug resistance in P. falciparum .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumAntimalarialsCoenzyme A LigasesArtemisininsDrug ResistanceMutationMalaria, FalciparumHumansProtozoan ProteinsQuinolinesWhole Genome SequencingPiperazines

Stichwörter der Autor:innen

Acetyl-CoA synthetasePlasmodium falciparumartemisinindrug resistance

Substanzen

AntimalarialsArtemisininsartenimolpiperaquineProtozoan ProteinsQuinolinesCoenzyme A LigasesPiperazines

Autor:innen und Institutionen

  • Yunnan Provincial Key Laboratory of Public Health and Biosafety & Department of Pathogen Biology and Immunology, Faculty of Basic Medical Science, Kunming Medical University, Kunming, Yunnan, China.
  • Department of Clinical Laboratory, the Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
  • Department of Infectious Diseases, Shanglin County People's Hospital, Chinese Center for Tropical Diseases Research Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Clinical Research Allian…
  • Department of Infectious Diseases and Hepatology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Department of Protozoan Diseases, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
  • Department of Advanced Biomedical Education, University of Mississippi Medical Center, Jackson, Mississippi, USA.

ORCID-Profile: Wei Zhao, Liwang Cui, Zhaoqing Yang

Förderung

  • NIAID NIH HHS
  • National Natural Science Foundation of China
  • Yunnan University Medical Research Fund
  • International Science and Technology Cooperation-Yunnan International Science and Technology Cooperation Base
  • NIH HHS
  • Yunnan Applied Basic Research Projects-Union Foundation
  • Guangxi Zhuang Autonomous Region Health Commission of Scientific Research Project
  • National Institutes of Health

Zitieren

APA

Zhao, W., Xiang, Z., Zeng, W., Qin, Y., Pan, M., Wu, Y., Duan, M., Mou, Y., Liang, T., Zhang, Y., Liu, C., Tang, X., Huang, Y., Yang, G., Cui, L., & Yang, Z. (2025). Acetyl-CoA synthetase mutations affect the susceptibility of Plasmodium falciparum to antimalarial drugs. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01026-25

Vancouver

Zhao W, Xiang Z, Zeng W, Qin Y, Pan M, Wu Y, et al. Acetyl-CoA synthetase mutations affect the susceptibility of Plasmodium falciparum to antimalarial drugs. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01026-25

BibTeX
@article{Zhao2025,
  author = {Zhao, Wei and Xiang, Zheng and Zeng, Weilin and Qin, Yucheng and Pan, Maohua and Wu, Yanrui and Duan, Mengxi and Mou, Ye and Liang, Tao and Zhang, Yanmei and Liu, Cheng and Tang, Xiuya and Huang, Yaming and Yang, Gongchao and Cui, Liwang and Yang, Zhaoqing},
  title = {Acetyl-CoA synthetase mutations affect the susceptibility of Plasmodium falciparum to antimalarial drugs},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01026-25}
}
Kostenlos starten →